Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibitionGabrielle S. Wong, Adam J. Bass, David Xu et al.|Nature Medicine|2018Cited by 282
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancerJenny Y. Xue, Piro Lito, Luciano G. Martelotto et al.|Nature Medicine|2017Cited by 181
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibitionGabrielle S. Wong, Adam J. Bass, Jin Zhou et al.|Nature Medicine|2018Cited by 10